Business Context and Reporting Period
Company: Upstart Holdings, Inc. (UPST)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Upstart operates an AI-powered lending marketplace facilitating unsecured personal loans, auto loans, and home equity lines of credit (HELOCs). The platform connects borrowers with lending partners and institutional investors, utilizing proprietary AI models for underwriting, fraud detection, and automation. In 2025, 91% of loans were fully automated.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenue | $1,043.9 million | $636.5 million | +64% |
| Revenue from Fees, Net | $950.0 million | $635.5 million | +49% |
| Net Income | $53.6 million | $(128.6) million | Turnaround to Profit |
| Adjusted EBITDA | $230.5 million | $10.6 million | +2,075% |
| Contribution Profit | $531.1 million | $381.5 million | +39% |
| Transaction Volume (Dollars) | $11.0 billion | $5.9 billion | +86% |
| Cash and Cash Equivalents | $652.4 million | $788.4 million | Decrease |
| Total Borrowings | $1,829.1 million | $1,402.2 million | +30% |
Note: The company reported a net income of $53.6 million in 2025, reversing a net loss of $128.6 million in 2024. This was driven by a significant reduction in unfavorable fair value adjustments on loans and beneficial interests.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 64% year-over-year, primarily driven by an 86% increase in transaction volume ($11.0 billion in 2025 vs. $5.9 billion in 2024). Platform and referral fees grew 58%.
- Profitability: The company returned to GAAP profitability, reporting net income of $53.6 million compared to a net loss of $128.6 million in 2024. Adjusted EBITDA margin expanded to 22% from 2%.
- Operating Expenses: Sales and marketing expenses increased 81% to $301.5 million due to higher advertising and acquisition costs. However, as a percentage of revenue, engineering and product development expenses decreased from 40% to 25%.
- Balance Sheet: Loans held on the balance sheet increased to $984.6 million (from $806.3 million), with 66% held for research and development purposes. Total borrowings increased to $1.83 billion, including the issuance of $690 million in 2032 Convertible Senior Notes.
- Credit Performance: While vintages from Q4 2023 and Q1 2024 are forecasted to underperform target returns due to macroeconomic conditions, vintages from Q2 2024 onward are forecasted to deliver returns in line with targets.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the strong 2025 performance to underwriting model improvements, product initiatives, and increased automation (91% of loans). The company expects to continue utilizing its balance sheet to support R&D and fill funding gaps during market constraints. The Upstart Macro Index (UMI) remained elevated at 1.39 as of year-end, indicating incremental macroeconomic risk.
Key Risks and Contingencies:
- Macroeconomic Sensitivity: Adverse economic conditions, rising interest rates, and inflation could reduce borrower demand and increase default rates, impacting credit performance and capital supply.
- AI Model Risk: The business relies heavily on the accuracy of AI models. Failure to accurately predict credit risk or adapt to changing economic conditions could lead to underperformance and reputational damage.
- Liquidity and Funding: The company depends on diverse capital sources from institutional investors and lending partners. Constraints in capital markets could force reliance on the balance sheet or more costly financing.
- Regulatory Environment: Evolving regulations regarding AI, fair lending, and bank partnership models (including "true lender" challenges) pose significant compliance risks.
- Legal Proceedings: The company is subject to ongoing securities class action litigation and derivative lawsuits alleging violations of securities laws and fiduciary duties. Outcomes are uncertain and could result in significant costs.
Investor Verification Checklist
- Credit Performance Trends: Verify the actual loss rates and recovery rates for the Q4 2023 and Q1 2024 vintages currently forecasted to underperform.
- Capital Supply Stability: Assess the renewal status and terms of committed capital and co-investment arrangements with institutional investors.
- Balance Sheet Exposure: Review the composition of the $984.6 million in loans held on the balance sheet, specifically the risk profile of the 66% held for R&D purposes.
- Regulatory Developments: Monitor ongoing regulatory inquiries and the status of the "true lender" legal challenges affecting the bank partnership model.
- Legal Liabilities: Track the progress of the consolidated securities class action and derivative litigation to estimate potential financial exposure.
- Debt Maturities: Confirm the company's ability to service or refinance the $66.5 million in 2026 Convertible Notes maturing in August 2026.